ELOX

Eloxx Pharmaceuticals, Inc.

OTCHealthcareBiotechnologyUS

USD10.00

+8.49 (+562.25%)

Rating:C+

Company Profile

CEO

Sumit Aggarwal

IPO Date

1999-04-26

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

Market Metrics

Open

$0.36

Prev. Close

$1.51

Day Low

$0.36

Day High

$10.00

52W Low

$0.00

52W High

$10.00

Market Cap

$0.08B

Volume

0.00M

News SentimentNeutral

Articles

Avg Positive

21.0%

Avg Negative

11.8%

Avg Neutral

66.9%

News Feed

Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update

GlobeNewsWire·8/16/2021·↑ positive

Hemogenyx Pharmaceuticals PLC Announces Appointment of Business Advisor & Board Observer

Accesswire·7/26/2021·↑ positive

Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis

GlobeNewsWire·7/6/2021